High dose rate brachytherapy as monotherapy for localised prostate cancer: a hypofractionated two-implant approach in 351 consecutive patients

MLA

Natasa Milickovic, et al. “High Dose Rate Brachytherapy as Monotherapy for Localised Prostate Cancer: A Hypofractionated Two-Implant Approach in 351 Consecutive Patients.” Radiation Oncology, vol. 8, no. 1, p. 115. EBSCOhost, https://doi.org/10.1186/1748-717x-8-115. Accessed 28 Nov. 2024.

APA

Natasa Milickovic, Markus Ratka, Ulf W. Tunn, Georgios Chatzikonstantinou, Nikolaos Zamboglou, Dimos Baltas, & Nikolaos Tselis. (n.d.). High dose rate brachytherapy as monotherapy for localised prostate cancer: a hypofractionated two-implant approach in 351 consecutive patients. Radiation Oncology, 8(1), 115. https://doi.org/10.1186/1748-717x-8-115

Chicago

Natasa Milickovic, Markus Ratka, Ulf W. Tunn, Georgios Chatzikonstantinou, Nikolaos Zamboglou, Dimos Baltas, and Nikolaos Tselis. 2024. “High Dose Rate Brachytherapy as Monotherapy for Localised Prostate Cancer: A Hypofractionated Two-Implant Approach in 351 Consecutive Patients.” Radiation Oncology 8 (1): 115. Accessed November 28. doi:10.1186/1748-717x-8-115.